Individually rare, collectively common – how do we transform the lives of people with rare diseases?
Clear national policy, collaboration with patients, and reviewing progress are key to tackling diagnosis, treatment and care challenges.
Innovation
Latest in
Innovation
Why the UK needs a strategic vision for science
Britain is trapped in “short term thinking”, says the world’s oldest scientific academy.
Partner content
How to turn the life sciences “superpower” ambition into reality
Partnership between the NHS, industry and research institutes is crucial to enable the UK to reach its clinical research potential.
By
Partner content
How will data and advancements in technology impact the NHS?
At the New Statesman’s Future of Healthcare conference, policymakers discussed the role that new technological frontiers will bring to the…
By
Partner content
How can the UK boost its life sciences sector to improve patient outcomes?
Britain has a strong background in pharmaceuticals and clinical trials but is struggling to achieve its full potential.
Partner content
Strengthening the UK’s clinical trial ecosystem
Why pharmaceutical companies play a role in driving progress.
By
Partner content
Ageing well with technology
Good design can transform the lives of older people.
Partner content
Can the UK be a life sciences superpower?
The answer is yes, but the window of opportunity is closing.
By